I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Bemelman, F. J.
456
results:
Search for persons
X
Format
Online (456)
Mediatypes
Articles (Online) (220)
Bookchapter (Online) (1)
OpenAccess-fulltext (235)
Sorted by: Relevance
Sorted by: Year
?
1
Eculizumab Rescue Therapy in Patients With Recurrent Atypic..:
Duineveld, Caroline
;
Bouwmeester, Romy N.
;
Wijnsma, Kioa L.
...
Kidney International Reports. 8 (2023) 4 - p. 715-726 , 2023
Link:
https://doi.org/10.1016/..
?
2
Long-term efficacy and safety of SARS-CoV-2 vaccination in ..:
Bouwmans, P.
;
Messchendorp, A. L.
;
Sanders, J. S.
...
BMC Nephrology. 23 (2022) 1 - p. , 2022
Link:
https://doi.org/10.1186/..
?
3
Proposal for individualized dosing of eculizumab in atypica..:
ter Avest, Mendy
;
Bouwmeester, Romy N
;
Duineveld, Caroline
...
Nephrology Dialysis Transplantation. 38 (2022) 2 - p. 362-371 , 2022
Link:
https://doi.org/10.1093/..
?
4
Rationale and design of the OPTIMIZE trial: OPen label mult..:
de Boer, S. E.
;
Sanders, J. S.F.
;
Bemelman, F. J.
...
BMC Nephrology. 22 (2021) 1 - p. , 2021
Link:
https://doi.org/10.1186/..
?
5
Incidence of hepatitis E infection in renal transplant pati..:
Erken, R.
;
Willemse, S.
;
Sinnige, M.
...
Journal of Hepatology. 68 (2018) - p. S757-S759 , 2018
Link:
https://doi.org/10.1016/..
?
6
DCD donor hemodynamics as predictor of outcome after kidney..:
Peters-Sengers, H.
;
Houtzager, J.H.E.
;
Heemskerk, M.B.A.
...
American Journal of Transplantation. 18 (2018) 8 - p. 1966-1976 , 2018
Link:
https://doi.org/10.1111/..
?
7
Early Conversion to Prednisolone/Everolimus as an Alternati..:
Bemelman, F.J.
;
de Fijter, J.W.
;
Kers, J.
...
American Journal of Transplantation. 17 (2017) 4 - p. 1020-1030 , 2017
Link:
https://doi.org/10.1111/..
?
8
Early Conversion From Calcineurin Inhibitor- to Everolimus-..:
de Fijter, J.W.
;
Holdaas, H.
;
Øyen, O.
...
American Journal of Transplantation. 17 (2017) 7 - p. 1853-1867 , 2017
Link:
https://doi.org/10.1111/..
?
9
Reversal of threatening blindness after initiation of eculi..:
Ramos de Carvalho, J. E.
;
Schlingemann, R. O.
;
Oranje, M.
..
International Ophthalmology. , 2017
Link:
https://doi.org/10.1007/..
?
10
Virus-Specific CD8+ T Cells Cross-Reactive to Donor-Alloant..:
Heutinck, K.M.
;
Yong, S.L.
;
Tonneijck, L.
...
American Journal of Transplantation. 16 (2016) 5 - p. 1480-1491 , 2016
Link:
https://doi.org/10.1111/..
?
11
Incidence, risk factors, and the impact of allograft pyelon..:
Singh, R.
;
Geerlings, S.E.
;
Peters‐Sengers, H.
...
Transplant Infectious Disease. 18 (2016) 5 - p. 647-660 , 2016
Link:
https://doi.org/10.1111/..
?
12
Immunization after renal transplantation: current clinical ..:
Struijk, G.H.
;
Lammers, A.J.J.
;
Brinkman, R.J.
...
Transplant Infectious Disease. 17 (2015) 2 - p. 192-200 , 2015
Link:
https://doi.org/10.1111/..
?
13
The effect of CYP3A4*22, CYP3A5*3 and CYP3A combined genoty..:
D.J.A.R., Moes
;
Swen, J.J.
;
den Hartigh, J.
...
Transplant Immunology. 31 (2014) 4 - p. 224 , 2014
Link:
https://doi.org/10.1016/..
?
14
Prophylaxis by trimethoprim–sulfamethoxazole does not reduc..:
Singh, R.
;
Geerlings, S.E.
;
ten Berge, R.J.M.
.
Transplant Immunology. 31 (2014) 4 - p. 231 , 2014
Link:
https://doi.org/10.1016/..
?
15
ABO-incompatible kidney transplantation outcomes: A single ..:
van Sandwijk, M.S.
;
Bemelman, F.J.
;
Donselaar-van der Pant, K.A.M.I.
...
Transplant Immunology. 31 (2014) 4 - p. 235 , 2014
Link:
https://doi.org/10.1016/..
1-15